» Authors » Qianlong Liu

Qianlong Liu

Explore the profile of Qianlong Liu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 227
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Sun X, Liu Q, Han C, Rao Y
J Am Chem Soc . 2024 Dec; 147(4):3110-3118. PMID: 39622049
Glioblastoma, a highly aggressive brain tumor, lacks effective treatment with low 5 year survival rates. Urgency for new therapies is evident. Mammalian targets of rapamycin (mTOR) and G1 to S...
2.
Liu Q, Yu Q, Fu J, Li P
Exp Ther Med . 2024 Jul; 28(3):344. PMID: 39006457
Cyst excision and Roux-en-Y hepaticojejunostomy (RYHJ) is the standard treatment for choledochal cysts (CCs). In the present study, the results of totally laparoscopic surgery for CCs (TLCCs) in a pediatric...
3.
Ni Z, Shi Y, Liu Q, Wang L, Sun X, Rao Y
Adv Sci (Weinh) . 2024 Apr; 11(25):e2308186. PMID: 38664976
Natural products, while valuable for drug discovery, encounter limitations like uncertainty in targets and toxicity. As an important active ingredient in traditional Chinese medicine, celastrol exhibits a wide range of...
4.
Ji C, Zhang C, Suo L, Liu Q, Peng T
ISA Trans . 2024 Mar; 147:227-238. PMID: 38443273
The chemical production process typically possesses complexity and high risks. Effective fault diagnosis is a key technology for ensuring the reliability and safety of chemical production processes. In this study,...
5.
Shi Y, Liao Y, Liu Q, Ni Z, Zhang Z, Shi M, et al.
Cell Discov . 2023 May; 9(1):47. PMID: 37156794
Biomolecular condensates play key roles in various biological processes. However, specific condensation modulators are currently lacking. PROTAC is a new technology that can use small molecules to degrade target proteins...
6.
Xie R, Zhang Y, Liu Q, Huang X, Liu M
Surg Innov . 2023 Jan; 30(5):636-639. PMID: 36592080
Background/need: Postoperative flap perfusion assessment methods still rely on the evaluation of traditional clinical indicators, which have the disadvantage of being subjective and burdensome. Methodology: This study describes a self-designed...
7.
Xie R, Liu Q, Zhang Y, Guo C, Huang X, Liu M
Int Wound J . 2022 Dec; 20(6):1839-1848. PMID: 36535065
The application of flap surgery is becoming more and more widespread with the development of microsurgical techniques. Currently, postoperative blood flow monitoring of flaps is still mainly assessed by medical...
8.
Fan Z, Yin Y, Cai B, Ma Q, Liu Q, Liu X, et al.
Chem Sci . 2022 Oct; 13(35):10512-10522. PMID: 36277621
Defect passivation along with promoted charge transport is potentially an effective but seldom exploited strategy for high-performance perovskite solar cells (PSCs). Herein, the defect passivation and carrier transport improvement are...
9.
Xie R, Xiao M, Li L, Ma N, Liu M, Huang X, et al.
Front Immunol . 2022 Oct; 13:925690. PMID: 36189280
Background: The systemic immune-inflammation index (SII) is a novel marker of inflammation, and hepatic steatosis and fibrosis are associated with inflammation. This study aimed to investigate the possible relationship between...
10.
Liu Q, Xiong N, Gong X, Tong H, Tan X, Guo X
Exp Ther Med . 2022 Sep; 24(4):621. PMID: 36160903
Kasabach-Merritt phenomenon (KMP) is a life-threatening condition caused by rare vascular tumors. To reduce drug resistance observed in monotherapy of KMP with prednisone, vincristine (VCR) or sirolimus, the present study...